Analysts have revised Bioceres Crop Solutions Corp.'s forecasts negatively, showing pessimism towards the company's near-term performance. Revenue and earnings estimates were slashed, with a 29% price target decrease. Despite the slowdown, Bioceres is still expected to outperform industry peers in growth.